Disease/Infection News

RSS

AHF applauds Gilead for licensing AIDS drugs to Medicines Patent Pool

AIDS Healthcare Foundation (AHF) today lauded Gilead Sciences for being the first major AIDS drug company to share some drug patents with a new international Medicines Patent Pool, a move that will help ensure access to newer AIDS treatments in developing countries.

13 Jul 2011

Gilead becomes first company to license drugs to Medicines Patent Pool

"In the first agreement between a pharmaceutical company and the new international Medicines Patent Pool, Gilead Sciences announced Tuesday that it would license four of its AIDS and hepatitis B drugs to the pool," the New York Times reports.

13 Jul 2011

Donors should continue to provide AIDS funding to China, UNAIDS head says

Cutting AIDS funding to China will "be a big mistake for a donor and particularly, for anyone who's invested in China today, ... for the simple reason that this funding is a catalytic fund," UNAIDS Executive Director Michel Sidibe told Reuters in an interview on Monday.

13 Jul 2011

New innovative device can eliminate malaria

Grand Challenges Canada announces a grant today to support further development of a new innovative device to attract and kill mosquitoes that can transmit malaria.

13 Jul 2011

Biologists discover new way in which bacteria hijack healthy cells during infection

Purdue University biologists identified a new way in which bacteria hijack healthy cells during infection, which could provide a target for new antibiotics.

13 Jul 2011

BRICS health ministers agree to improve access to low-cost medicines

Health ministers from Brazil, Russia, India, China, and South Africa in Beijing "on Monday vowed to improve access to low-cost and high-quality medicine - and called on developed nations to shoulder responsibility in helping the poor," Agence France-Presse reports.

13 Jul 2011

Study reveals link between HPV infection and SCC in organ transplant recipients

A new study published in the American Journal of Transplantation reveals an association between the human papillomavirus (betaPV) infection and cutaneous squamous cell carcinoma (SCC) in organ transplant recipients.

13 Jul 2011

Sexually transmitted diseases more common in women age 40

A Johns Hopkins infectious disease expert is calling for all sexually active American women age 40 and older to get tested for the parasite Trichomonas vaginalis after new study evidence found that the sexually transmitted disease (STD) is more than twice as common in this age group than previously thought.

12 Jul 2011

USPTO issues notice of allowance to MDI's PCR-based technology platform

Molecular Detection Inc. (MDI), a company developing Detect-Ready assays designed to increase the speed and accuracy of infectious disease diagnosis, today announced that it has received a notice of allowance from the US Patent and Trademark Office (USPTO) for a patent application titled "Methods, Compositions and Kits for Detection and Analysis of Antibiotic Resistant Bacteria."

12 Jul 2011

Gilead, Mylan expand license deal for HIV/AIDS medicines

Mylan Inc. today announced an expanded licensing agreement between Gilead Sciences Inc. and Mylan's Matrix Laboratories Limited.

12 Jul 2011

Rapid method can predict immune responses against flu vaccines

Researchers at the Emory Vaccine Center have developed a method for predicting whether someone will produce high levels of antibodies against a flu shot a few days after vaccination.

12 Jul 2011

HIV patients with mental illness can benefit from APRN care management

In a four-year study, researchers at the University of Pennsylvania have found that assigning adults with serious mental health illness who are HIV positive to the care of advanced practice nurses (APRN) to help navigate the health care system and maintain adherence to drug regimens reduced depression and improved their overall physical health, indicating that healthcare policy should be revamped to provide this support.

12 Jul 2011

UNC receives $32 million federal grant to eradicate HIV infection

Researchers at the University of North Carolina at Chapel Hill have been awarded a $32 million, five-year federal grant to develop ways to cure people with HIV by purging the virus hiding in the immune systems of patients taking antiretroviral therapy.

12 Jul 2011

Haiti passed up cholera vaccine offer, Crucell CEO says

Ronald Brus, CEO of the Dutch vaccine maker Crucell, said Haiti did not accept an offer of tens of thousands of cholera vaccine doses late last year, the Financial Times reports.

12 Jul 2011

Type-3 polio virus case in Pakistan raises concerns of disease spreading, WHO says

Pakistan has reported the first case of the type-3 wild polio virus in six months, raising concerns that the disease may spread to other parts of Asia and beyond, the WHO said on Thursday, Bloomberg/San Francisco Chronicle reports.

12 Jul 2011

New research strategy for eradicating HIV from the body

An international team led by researchers from the University of California, San Francisco and the nonprofit Vaccine and Gene Therapy Institute of Port St. Lucie, Fla., has received a major grant from the National Institutes of Health to develop a strategy to eradicate HIV from the body.

12 Jul 2011

Merck researchers to participate in two new collaborative efforts to study HIV latency

Merck, known as MSD outside the United States and Canada, today announced that company researchers will participate in two new collaborative efforts led by the prominent academic institutions of the University of North Carolina (UNC) Chapel Hill and the University of California San Francisco (UCSF) to develop new approaches towards eradicating HIV, the virus that causes AIDS.

12 Jul 2011

Gilead announces expansion of global access program for HIV medications

Gilead Sciences, Inc. announced today an expansion of its global access program in an effort to provide accelerated access to Gilead medicines for the treatment of HIV/AIDS.

12 Jul 2011

Hutchinson Center receives $20M NIH grant to eradicate HIV infection

Whether a stem cell transplant using an HIV-infected person's own genetically modified immune cells can become a cure for the disease is the focus of a new $20 million, five-year research grant award announced today by the National Institutes of Health to Fred Hutchinson Cancer Research Center.

12 Jul 2011

Scientists to receive prestigious awards for innovative HIV research at IAS 2011

The International AIDS Society (IAS) announced today the six winners of three prestigious scientific awards, to be presented at plenary sessions during the 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention to be held in Rome July 17-20, 2011.

12 Jul 2011